SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Abbott Initiates Pivotal Trial of Cephea Mitral Valve Device

The CROWN-MV trial will evaluate the safety and effectiveness of the investigational Cephea device for mitral valve disease.

ABT
SquawkNews Desk 1 updates Updated Oct 29, 2026, 01:11 PM UTC

Story updates

01:11:29 PM UTC
SquawkNews
Abbott inicia ensayo pivotal de Cephea para reemplazo de válvula mitral Abbott inició el 29 de o

Related stories

Australian Energy Stocks Reach One-Week High as Oil Rises Australian energy stocks reached a one-week high as supply concerns lifted oil prices. M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC Nasdaq 100 futures fall 2%; S&P 500 futures down almost 1% M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC U.S. Stock Futures Fall as Intel and Amazon Earnings Weigh At 11:44 p.m. EDT, Dow futures fell 0.17%, S&P 500 futures fell 0.95% and Nasdaq-100 futures fell more than 2% after disappointing earnings from Intel and Amazon. M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC Janome to Buy Back Up to 5.98% of Shares L impact | EQUITY | Oct 30, 2026, 04:02 AM UTC Asian session market picture: S&P 500 -0.94%, Nasdaq 100 -2.06%; USD/JPY -0.15%, WTI +1.18%, 1810 leads volume Asian session market picture. US index futures: S and P futures is down 0.94 percent, Nasdaq futures is down 2.06 percent, Dow futures is down 0.19 percent and Russell futures is d M impact | EQUITY | Oct 30, 2026, 04:00 AM UTC Hengsheng Real Estate Delisted on Nov. 3 Hengsheng Real Estate’s listing status was formally revoked on Nov. 3. L impact | EQUITY | Oct 30, 2026, 03:59 AM UTC